Attached files
file | filename |
---|---|
EX-32.2 - AIM ImmunoTech Inc. | ex32-2.htm |
EX-32.1 - AIM ImmunoTech Inc. | ex32-1.htm |
EX-31.2 - AIM ImmunoTech Inc. | ex31-2.htm |
EX-31.1 - AIM ImmunoTech Inc. | ex31-1.htm |
EX-23.2 - AIM ImmunoTech Inc. | ex23-2.htm |
EX-21 - AIM ImmunoTech Inc. | ex21.htm |
EX-10.81 - AIM ImmunoTech Inc. | ex10-81.htm |
EX-10.80 - AIM ImmunoTech Inc. | ex10-80.htm |
EX-10.79 - AIM ImmunoTech Inc. | ex10-79.htm |
EX-10.78 - AIM ImmunoTech Inc. | ex10-78.htm |
EX-10.77 - AIM ImmunoTech Inc. | ex10-77.htm |
EX-10.76 - AIM ImmunoTech Inc. | ex10-76.htm |
EX-10.75 - AIM ImmunoTech Inc. | ex10-75.htm |
EX-4.23 - AIM ImmunoTech Inc. | ex4-23.htm |
10-K - AIM ImmunoTech Inc. | form10-k.htm |
Exhibit 23.1
Consent of Independent Registered Public Accounting Firm
AIM ImmunoTech Inc.
Ocala, Florida
We hereby consent to the incorporation by reference in the Registration Statements on Form S-8 (No. 333-118903, 333-155528, 333-160499, 333-209060, 333-220296, 333-227543 and 333-240315), Form S-3 (No. 333-205228 and 333-226059) and Form S-1 (No. 333-217671, 333-220756, 333-226057, 333-229051 and 333-233657) of AIM ImmunoTech Inc. of our report dated March 30, 2021, relating to the consolidated financial statements, which appears in this Form 10-K.
/s/ BDO USA, LLP
Miami, Florida
March 30, 2021